Formulation and in vitro evaluation of ibuprofen-carbopol® 974P-NF controlled release matrix tablets III:: influence of co-excipients on release rate of the drug

被引:78
作者
Khan, GM [1 ]
Jiabi, Z [1 ]
机构
[1] China Pharmaceut Univ, Zhong Kun Pharmaceut Res Inst, Nanjing 210009, Peoples R China
关键词
controlled release; ibuprofen; carbopol (R); co-excipients;
D O I
10.1016/S0168-3659(97)00225-3
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In order to assess the potential of carbopol(R) 974P-NF as matrix material in hydrophilic matrix tablets containing a slightly water-soluble drug, ibuprofen (IBF), controlled release matrix tablets of ibuprofen and carbopol(R) 974P-NF, at different drug to polymer ratios, were prepared by the direct compression method. The influence of the concentration of the matrix material (carbopol(R) 974P) and several co-excipients (lactose, microcrystalline cellulose, and starch) on the release rare of the drug was investigated. An in vitro dissolution test in pH 7.2 phosphate buffer solution showed that drug release from all the formulations containing carbopol(R) 974P was considerably prolonged in concentration-dependent manners. Increasing the amount of carbopol(R) 974P in tablets resulted in a reduction in the drug release rate and a linearization of the drug release curve. When the influence of the co-excipients on the release of the drug was examined, all of the co-excipients used in this study enhanced the release rate of IBF. However, lactose demonstrated slower and more linear release behavior as compared in microcrystalline cellulose or starch. The dissolution T-50 and T-90 values for the to er co-excipients were in the order of lactose>microcrystalline cellulose>starch. (C) 1998 Published by Elsevier Science B.V.
引用
收藏
页码:185 / 190
页数:6
相关论文
共 12 条
[1]  
[Anonymous], 1985, J PHARM SCI
[2]   CONTROLLED-RELEASE THEOPHYLLINE TABLET FORMULATIONS CONTAINING ACRYLIC RESINS .3. INFLUENCE OF FILLER EXCIPIENT [J].
CAMERON, CG ;
MCGINITY, JW .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1987, 13 (02) :303-318
[3]  
CAPAN Y, 1991, EUR J PHARM BIOPHARM, V37, P14
[4]  
CHILAMKURTI RN, 1983, PHARM ACTA HELV, V58, P251
[5]   STUDIES ON DRUG-RELEASE KINETICS FROM CARBOMER MATRICES [J].
DURRANI, MJ ;
ANDREWS, A ;
WHITAKER, R ;
BENNER, SC .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1994, 20 (15) :2439-2447
[6]  
GOODRICH BF, 1994, B CARBOPOL PROVEN PO
[7]   STUDIES ON DRUG-RELEASE FROM A CARBOMER TABLET MATRIX [J].
HUANG, LL ;
SCHWARTZ, JB .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1995, 21 (13) :1487-1501
[8]  
KHAN GM, IN PRESS INT J PHARM
[9]  
KHAN GM, IN PRESS J CHINA PHA
[10]  
MARCOS BP, 1991, J CONTROL RELEASE, V17, P267